Department of Pharmaceutics, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 151 Malianwa North Road, Haidian District, Beijing 100193, China.
Molecules. 2018 Nov 16;23(11):2990. doi: 10.3390/molecules23112990.
For drugs with high hydrophilicity and poor membrane permeability, absorption enhancers can promote membrane permeability and improve oral bioavailability. Sodium -[8-(2-hydroxybenzoyl)amino]caprylate (SNAC) is a new kind of absorption enhancer that has good safety. To investigate the absorption enhancement effect of SNAC on non-polar charged and polar charged drugs and establish the absorption enhancement mechanism of SNAC, SNAC was synthesized and characterized. Two representative hydrophilic drugs-notoginsenoside R1 (R1) and salvianolic acids (SAs)-were selected as model drugs. In vitro Caco-2 cells transport and in vivo rat pharmacokinetics studies were conducted to examine the permeation effect of SNAC on R1 and SAs. R1, rosmarinic acid (RA), salvianolic acid B (SA-B) and salvianolic acid B (SA-A) were determined to compare the permeation enhancement of different drugs. The MTT assay results showed that SNAC had no toxicity to Caco-2 cells. The transepithelial electrical resistance (TEER) of Caco-2 cell monolayer displayed that SNAC facilitated passive transport of polar charged SAs through the membrane of epithelial enterocytes. The pharmacokinetics results demonstrated that area under the curve (AUC) of RA, SA-B and SA-A with administration of SAs containing SNAC was 35.27, 8.72 and 9.23 times than administration of SAs. T of RA, SA-B and SA-A were also prolonged. The AUC of R1 with administration of R1 containing SNAC was 2.24-times than administration of R1. SNAC is more effective in promoting absorption of SAs than R1. The study demonstrated that SNAC significantly improved bioavailability of R1 and SAs. What's more, the effect of SNAC on absorption enhancement of charged drugs was larger than that of non-charged drugs. The current findings not only confirm the usefulness of SNAC for the improved delivery of R1 and SAs but also demonstrate the importance of biopharmaceutics characterization in the dosage form development of drugs.
对于亲水性强、膜透过性差的药物,可以使用吸收促进剂来促进药物的膜透过性,提高口服生物利用度。[8-(2-羟基苯甲酰基)氨基]辛酸钠(SNAC)是一种新型的吸收促进剂,具有良好的安全性。为了研究 SNAC 对非极性带电和极性带电药物的吸收增强作用,并建立 SNAC 的吸收增强机制,合成并对 SNAC 进行了结构鉴定。选择两种具有代表性的亲水性药物-三七皂苷 R1(R1)和丹酚酸(SAs)作为模型药物。通过体外 Caco-2 细胞转运实验和体内大鼠药代动力学实验,考察了 SNAC 对 R1 和 SAs 的渗透作用。通过比较不同药物的渗透增强作用,测定了 R1、迷迭香酸(RA)、丹酚酸 B(SA-B)和丹酚酸 A(SA-A)。MTT 实验结果表明,SNAC 对 Caco-2 细胞无毒性。Caco-2 细胞单层跨上皮电阻(TEER)实验显示,SNAC 促进极性带电 SAs 经上皮肠细胞的膜被动转运。药代动力学结果表明,与不含 SNAC 的 SAs 给药组相比,含 SNAC 的 SAs 给药组 RA、SA-B 和 SA-A 的 AUC 分别增加了 35.27、8.72 和 9.23 倍,RA、SA-B 和 SA-A 的 T 也延长。与不含 SNAC 的 R1 给药组相比,含 SNAC 的 R1 给药组 R1 的 AUC 增加了 2.24 倍。SNAC 促进 SAs 的吸收作用强于 R1。该研究表明,SNAC 可显著提高 R1 和 SAs 的生物利用度。此外,SNAC 对带电药物吸收增强的效果大于非带电药物。这些发现不仅证实了 SNAC 可用于改善 R1 和 SAs 的递送,还证明了生物药剂学特征在药物剂型开发中的重要性。